论文部分内容阅读
目的:探讨宫颈液基细胞(TCT)与人乳头状病毒(HPV)联合作为宫颈癌的初筛的临床意义。方法:选取在我院门诊就诊要求进行宫颈癌初筛并有一年以上性生活史妇女500名,根据不同检验方式分为病理检验组和HPV联合TCT检验组,而后分析两组的检验差异。结果:在宫颈癌检出率上,两组差异统计学差异,同时在浸润癌、CINⅠ、CINⅡ、CINⅢ的诊出率上,与病理结果没有显著性差异。结论:HPV与TCT联合检验法应用于宫颈癌初筛的临床诊断过程,可提高检出率,减轻患者精神负担及肉体痛苦,节约经费、缓解经济压力。
Objective: To investigate the clinical significance of cervical liquid-based cells (TCT) combined with human papillomavirus (HPV) as primary screening of cervical cancer. Methods: 500 women who were screened for cervical cancer and had a history of more than one year in our outpatient clinic were divided into pathological examination group and HPV combined with TCT test group according to different test methods, and then the differences between the two groups were analyzed. Results: In the detection rate of cervical cancer, the difference between the two groups was statistically significant. There was no significant difference between the two groups in the diagnosis rate of invasive carcinoma, CINⅠ, CINⅡ and CINⅢ. Conclusion: The combined test of HPV and TCT can be used in clinical diagnosis of cervical cancer screening, which can improve the detection rate, reduce the mental burden and physical pain, save money and relieve the economic pressure.